Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2225811 | 1.00 | ANPEP (0.47) | ANPEPERAP2ADRB3KMT2AHPGD | |
| SCHEMBL2221988 | 0.84 | ANPEP (0.48) | ANPEPERAP2KMT2AHPGDMEN1 | |
| SCHEMBL2221986 | 0.84 | ANPEP (0.48) | ANPEPERAP2KMT2AHPGDMEN1 | |
| SCHEMBL18426210 | 0.82 | KMT2A (0.58) | ANPEPKMT2AHPGDALDH1A1MEN1 | |
| Pregabalin SCHEMBL16099769 | 0.80 | CACNA2D1 (0.58) | ANPEPKMT2AHPGDALDH1A1MEN1 | |
| SCHEMBL16114938 | 0.78 | CACNA2D1 (0.61) | KMT2AALDH1A1MEN1 | |
| SCHEMBL27598436 | 0.77 | CPA1 (0.53) | ANPEP | |
| SCHEMBL13416723 | 0.76 | ALDH1A1 (0.56) | ANPEPERAP2HPGDALDH1A1ADRB2 | |
| SCHEMBL28529991 | 0.75 | ANPEP (0.54) | ANPEPERAP2ADRB3KMT2AHPGD | |
| SCHEMBL25523120 | 0.74 | CTSK (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011086566-A1 | METHOD OF RESOLUTION OF (RS) - 1, 1 ' - BI - 2 - NAPHTHOL FOR OBTAINING ENANTIOMERIC PURE I.E. (S) - (-) \" 1, 1 ' \"BI - 2 -NAPHTHOL AND/OR (R) - ( ) - 1, 1 ' - BI - 2 - NAPHTHOL VIA CO - CRYSTAL FORMATION WITH OPTICALLY ACTIVE DERIVATIVES OF GAMMA -AMINO ACIDS | LUPIN LIMITED (IN) | 2011-07-21 | — | — | WO | disclosed |